<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 52 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page51.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=52">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 52 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 52</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=52"><img src="../thumb/52.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.4.7 / 1.4.8 / 1.4.9                                  2020-04 / 21
       sympts.occur whch are sev./abrupt in onset/not part of pres.sympts.,   MYLAN MIRTAZAPINE, (Mylan) Xixia [P/S]  Dosage: Init: 15 mg/day which may be grad.incr. accord.to clinic.
       grad.withdr., elderly, micturit.disturbs., clos.angle glauc., incr.IOP  Mirtazapine  respons.. Effect. dos.range: 15-45 mg/day. Dos. given as sngl.bedt.
       Drug interactions: Potent.CNS depress.act.of alcoh., sedat.effs.of   Indications: Maj.depress.  dos./in 2 equal. div.dos. Changes to be made at interv.of at least 1-2
       anxiolyt.& hypnot.potent.     (S5) TABS, 41/1.2/0367, 0368.  wks. Cont.treatm.x6 mnths.for ac. depress.episod.
       BERON, Aurobindo [P/S]        710802-001: 15 mg, 30, R211,87  Contraindications: Pregn., lactat., childr., use not recomm. in com-
                                     710803-001: 30 mg, 30, R321,96
                                                                  binat.with MAOI/within 14 days of discont.MAOI ther.
       Mirtazapine                   Dosage: Cont.ther.x6mnths.for ac.depress. episod.  Side effects: Asthen., flu syndr., incr.sweat., sedat., CNS effs.,
       Indications: Maj.depress.     Init: 15 mg/day as sngl.dos.at bedt.which may be grad.incr.accord.to   epilept.seiz., mania, convuls., myoclonus, restless legs, incr.appet.,
       (S5) TABS. A40/1.2/0366, 0367  clinic.respons. Effect.dos. range: 15-45 mg/day. Dos.changes to be   weight gain, GI disturbs., thirst, bitter taste, oed., periph. oed., pos-
       710528-001: 15 mg, 30, R274,45  made at interv. of not less than 1-2 wks.  tur.hypotens., exanthem, jaund., revers. agranulocytos., leucopen.,
       710529-001: 30 mg, 30, R418,03  Contraindications: Pregn., lactat., childr., MAOI  granulocytopen., arthralg., myalg.
       Dosage: Init: 15 mg/day as sngl.dos.pref.at bedt. or in 2 equal.div.dos.   Side effects: Flu like syndr., asthen., incr. sweat., CNS effs., paraes-  Special precautions: Epilep., hepat./ren. insuffic., card.dis., con-
       Incr.grad.accord.to clinic. respons. Effect.dos.range usual.15-45 mg/  thes., epilept.seiz., man., convuls., myoclon., restless leg syndr., incr.   duct.disturbs., ang.pect., recent MI, hypotens., diab.mellit., psychos.,
       day. Dos. chang.to be made at interv.of at least 1-2 wks. Cont.treatm.  appet., weight gain, dry mouth, GI disturbs., thirst, bitter taste, oed.,   bi-pol. disord.hist., discont.in case of jaund., discont. if sympts.of in-
       for at least 6 mnths.in ac. depress. episod.  periph.oed., postur. hypotens., exanthem, jaund., revers. agranulocy-  fect.occur & do bld.counts, worsen. depress./emerg.suicide ideat./-
       Contraindications: Pregn., lactat., childr., concom. MAOI/ within   tos./ leucopen.& granulocytopen., arthralg., myalg.  behav. risk in maj. depress./other psych./non-psych. disords., monit.
       14 days of discont.MAOI ther.  Special precautions: Epilep., hepat./ren. insuffic., card.dis., con-  pts. esp.dur.early ther.& dos. changes for clinic. worsen./suicid.ideat./-
       Side effects: Psych.effs.incl.akathisia, asthen., flu syndr., incr.sweat.,   duct.disturbs., ang.pect., recent MI, hypotens., diab.mellit., psychos.,   behav., consid. change. therapeut.regim/discont.if psych. sympts
       CNS effs., vertigo, epilept. seiz, paraesthes., restl.legs syndr., incr.  bipol. disord.hist., discont.in case of jaund., discont.if sympts.of in-  occur which are sev./abrupt in onset/not part of pres. sympts., grad.
       appet., weight gain, GI disturbs., thirst, bitter taste, oed., hypotens.,   fect.occur & do bld.counts, worsen. depress./emerg.suicid.ideat.&   withdr., micturit. disturbs., clos. angle glauc., incr.IOP
       exanthem., jaund., bld. dyscras., arthralg., myalg.  behav., monit.pts.caref.dur.early ther.& dos.changes for clinic. wors-  Drug interactions: Potent.CNS depress.act.of alcoh., sedat.effs.of
       Warnings and special precautions: Epilep., hepat./ren. insuff.,   en./suicidality, co-morbid.betw. maj. depress.disord.& other psych./  anxiolyt./hypnot.potent.
       card.disords.eg.conduct. disturbs., ang. pect., recent MI, hypotens.,   non-psych. disords., consid.chang. therapeut.regim/discont.if psych.
       diab. mellit., psychos., bipol.disord.hist., discont. treatm. if jaund. de-  sympts.occur whch are sev./abrupt in onset/ not part of pres.sympts.,
       vel., discont.if sympt.of infect. occur & do bld.count, suic.risk, caref.  grad.withdr., elderly, micturit.disturbs., clos.angle glauc., incr. IOP
       monit.esp.at begin. of ther./dos.chang., consid.chang. therapeut.   Drug interactions: Potent.CNS depress.act.of alcoh., sedat.effs.of  1.4.8   Melatonergic specific
       regim./discont.ther.if psych.effs.sev./ abrupt onset/sympt.not present   anxiolyt.& hypnot.potent.
       init., co-morbid. betw. maj. depress.disord.& other psych./non psych.   MYTRA, Novagen [P/S]  VALDOXANE, Servier [P/S]
       disords., grad.withdr., elderly, micturit. disturbs., clos.-angle glauc.,   Agomelatine
       rais.IOP, concom. anxiolyt./ hypnot.meds., avoid alcoh.  Mirtazapine  Indications: Maj.depress.episodes.in adults
                                     Indications: Maj.depress.
       Drug interactions: Poss.potent.CNS sedat.effs. of anxiolyt./  (S5) TABS, A40/1.2/0347
       hypnot./alcoh.                (S5) TABS, A40/1.2/0652, 0653.  716215-001: 25 mg, 28, R375,90.
                                     714684-001: 15 mg, 30, R251,42
       LAMICTIN, GlaxoSmithKline SA (Pty) Ltd  714685-001: 30 mg, 30, R391,07  Dosage: Treat for at least 6 mnths to ensure pt.sympt.free. Not
       See Section 1.6               Dosage: Cont.ther. for at least 6 mnths.for ac. depress. episod.  necess.to taper dos.on discontinuat.
                                                                  Recomm.dos: Adults: 25 mg once dly.at bedt., if aft.sever.wks.no
       LANTANON, MSD [P/S]           Init: 15 mg/day as sngl.dos.pref.at bedt.or in 2 equal.div.dos. May be   further clinic.improvem.noted may be incr.to 50 mg once dly.
                                     grad.incr.accord.to clinic. respons. Effect.dos.range: 15-45 mg/day.
       Mianserin HCl.                Dos. chang. to be made at interv.of at least 1-2 wks.  Contraindications: Hepat.impairm., concom. potent CYP1A2 inhib-
       Indications: Depress.         Contraindications: Pregn., lactat., childr., MAOI.  it., safety & effic.in childr. und. 18 yrs.not est., elderly with dement.
       (S5) TABS. J/1.2/64, N/1.2/180.  Side effects: Withdr.sympt., flu like syndr., asthen., incr.sweat.,   as safety & effic.not est., safety & effic.dur.pregn.& lactat. not est.
       735795-002: 10 mg, 30, R124,09  CNS effs., dizzin., trem., epilept. seiz., vertigo, convuls., mania, par-  Side effects: Liv.enzme elev.&gt;10 times upper limit of norm., hepatit.,
       735795-010: 10 mg, 90, R372,28  aesthes., headache, myoclon., restless leg syndr., incr.appet., weight   jaund., naus., dizzin., somnol., insomn., migraine, paraesthes., psych.
       735817-022: 30 mg, 40, R433,10  gain, GI disturbs., thirst, bitter taste, oed., periph.oed., postur.hypo-  disords., anx., suic.thoughts/behav., agitat.& relat. sympts., mania/
       Dosage: Init: 30-40 mg dly.in the even. Maint:30-90 mg (gen.60 mg) dly.  tens., exanthem, jaund., revers.agranulocytos./ leucopen. & granu-  hypoman., blurr.vis., GI disturbs., hyperhidros., eczema, prurit., ery-
       Contraindications: Mania, sev.liv.dis., childr.& adolesc.und.18 yrs.,   locytopen., arthralg., myalg.  themat. rash, back pain, fatig., incr./decr. weight.
       MAOI, safety in pregn.& lactat. not est.  Special precautions: Caref.dos.& reg.monit.in follow.condits: epi-  Special precautions: Not recom.in pts.&gt;65yrs. as effic.not clearly
       Side effects: Bone marr.depress., weight incr., hypomania, sedat.,   lep./hepat.or ren.insuffic./card. dis./ conduct.disturbs./ang.pect./re-  demonstrat., bi-pol./mania/ hypoman. hist., discont.if manic sympts.
       convuls., restless legs, neurolept. malign.syndr., dizzin., dilat./con-  cent MI/ hypotens., diab.mellit., psychos., bipol.disord. hist., discont.  develop, monit.for incr.suicid.thoughts partic.in early stages of recov-
       strict. pupils, bradycard., hypotens., vomit., elev.liv. enzym, jaund.,   in case of jaund., treatm.to be stopp. & bld.count perform.if S&S of   ery & pts.&lt;25 yrs., suicide relat. event hist., concom.mod.CYP1A2 in-
       hepatit., exanthema, arthralg., gynaecomast., oed., atax., suicid.  infect.occur, worsen. depress./emerg.suicid.ideat.& behav., monit.   hibit.(eg oestrog. & propranolol), pre-treatm.elev. transamin., liv.funct.
       ideat./-behav.                pts.caref.dur.early ther.& dos.changes for clinic. worsen./suicidality,   tests for all pts.at init./when incr.dos.at 3-6-12-24 wks.& sympts.
       Special precautions: Suicide relat.behav.& hostility more freq.  co-morbid.betw.maj. depress. disord. & other psych./non-psych. dis-  suggest. hepat. dysfunct., rep.liv.funct.tests within 48 hrs. of incr.
       observ.in childr./adolesc. & &lt;25 yrs. treat.with antidepress.in clinic.  ords., consid.chang.therapeut.regim./discont.if psych. sympts.occur   ser.transaminas., discont.ther.if ser. transaminas. exceed 3xULN &
       trials compar.to those treat.with placebo, monit.for suicide/suicid.   whch are sev./abrupt in onset / not part of pres.sympts., grad.withdr.,   perform LFT reg. until return to norm., do not re-introd.ther.if S&S
       thoughts or clinic.worsen.dur.early treatm.& dos. changes, monit.  avoid alcoh., elderly, micturit.disturbs., clos.angle glauc., incr. IOP.  of liv.injur.pres., pre-treatm.elev.transaminas. &gt;ULN and &lt;3xULN,
       BP with concom.antihypertens. ther., elderly, hypoman.poss.pre-  Drug interactions: Potent.CNS depress.act.of alcoh., sedat.effs.of   hepat.injury risk fact., obesity/ non-alcoh.fatty liv.dis., substant.al-
       cipit.with bipol. depress.illn.in which case withdr., withdr.if jaund./   anxiolyt.& hypnot.potent.  coh. ingest., meds.assoc.with hepat.injury risk, concom. alcoh.not
       convuls.occurs., diabet., CV disords., hepat./ ren. insuffic., narr.angle   REMERON, MSD [P/S]  advis., no exper.with ECT ther., interact.stud.only perform.with adults,
       glauc., prostat.hypertrophy,                               sev. to mod.ren.impairm., not for pts with rare heredit. galact.intol.
       Drug interactions: CNS depress.act.of alcoh. potent., poss.reduc.  Mirtazapine  probl./Lapp lact.defic or gluc.galact. malabsorpt., smok.(esp.heavy
                                     Indications: Maj.depress.
       plasma lev.with CYP3A4 induc. antiepilept.meds., may affect warfarin.  (S5) TABS. 32/1.2/0481, 0482.  smok.)decr. bioavail.
       MIRADEP, (Cipla Medpro) Zydus [P/S]  897760-018: 15 mg, 30, R514,87  Drug interactions: Potent CYP1A2 inhibit. (eg.fluvoxamine & cip-
                                                                  rofloxacin) & mod. CYP2C9 inhibit. markedly inhibit.metabol.incr.
       Mirtazapine                   842958-002: 30 mg, 30, R782,19  expos., mod. CYP1A2 inhibit.(eg oestrog./propranolol) incr. expos.
       Indications: Maj.depress.     Dosage: Init: 15 mg/day as sngl.dos.at bedt. Effect. dos.range: 15-  several fold, rifampic.decr.bioavail.
       (S5) TABS, 44/1.2/1007, 1008  45 mg/day. Dos.changes to be made at interv.of not less than 1-2 wks.
       721209-001: 15 mg, 30, R221,44  Contraindications: Pregn., lactat., childr., recomm.not to be used
       721210-001: 30 mg, 30, R336,49  in combinat.with MAOI/ within 14 days of init/ discont.MAOI ther.
       Dosage: Swall.whole without chew. Init: 15 mg/ day which may be   Side effects: Sedat., bone marr.depress.present. as granulocytopen./  1.4.9  Lithium
       grad.incr.accord.to clinic. respons. Effect.dos.range: usual.15-45 mg/  revers.agranulocytos., incr. appet., weight gain, asthen., flu syndr., incr.
       day as sngl.dos.pref.at bedt.or in 2 equal.div.dos. Dos. chang. to be   sweat., oed., periph.oed., CNS effs., GI disturbs., orthostat.hypotens.,   CAMCOLIT (MDR Listing)
       made at interv.of not less than 1-2 wks. Cont. ther.for at least 6 mnths.  epilept.seiz., man., convuls., myoclon., exanthem, thirst, bitter taste,   CAMCOLIT, Aspen Pharmacare: Pharma [P/S] &
       for ac. depress. episod.      rash, S/E of which causal relationship not est: hypertens., vasodilat.,   Lithium carbon.
       Contra-indications: Pregn., lactat., childr., MAOI, lact.intol.  myalg., myasthen., arthralg., dyspn., incr.cough, sinusit., urin.freq., UTI,   Indications: Treatm.& relapse prev.of man.& manic depress.illn.
       Side-effects: Bld.dyscras., incr.appet./sweat., mass gain, hy-  face oed., photosens., enlarg.abdom., ang.pect., MI, other CV effs.,   (S5) TABS. B1260, L/1.2/161.
       ponatraem., psych.disords.incl. depersonalisat./hostilit./anx., CNS   syncope, migraine, hypotens., eructat., incr. cholesterol & triglycerid.  712078-002: 250 mg, 100, R403,37
       effs., dizzin., tremor, vertigo, seiz., hyperaesthes., headache, myo-  (non-fast.), atax., delir., delus., depersonlisat., hallucinat., man.react.,   712078-010: 250 mg, 1 000, R4 034,00
       clon., restl.legs/seroton.syndr., oed.incl. periph. oed., postur.hypotens.,   neuros., dyston., hostility, emot.lability, euphor., paranoid react., con-  712086-005: 400 mg, 100, R432,33
       dyspn., dry mouth, GI disturbs., bitter taste, incr.liv.enzym.lev., jaund.,   junctivit., keratoconjunctivit., lacrimat.disord., glauc., hyperacus., dys-  Dosage: Ac.mania: Reqd.dly.dos.may be admin. either in div.dos.
       skin reacts., arthralg., myalg., hypo-/hyperkines., back pain, urin.freq.,   kines., extrapyramid.syndr., incr.libido, abnorm.co-ordinat., dysarthr.,   or as sngl.dly dos.
       menstr.chang., impot., malaise, asthen., flu like syndr.  incr.reflex., eye/ear pain, vis. disturbs., deafn., kidn.calcul., cystit.,   Init.in hosp.where reg.Li lev.monit. Dos.adjust.to keep Li lev.in ther.
       Special precautions: Epilep., hepat./ren.insuff., monit.card.dis-  dysur., urin. incontin./retent., impot.  range of 0,6-1,0 mmol/L. Init. 1 000-1 500 mg dly for 1 5-7 days.
                                                                                          st
                                     Special precautions: Epilepsy, organ.brain sympts., hepat./ren.
       ords.incl.conduct. disturbs./ang.pect. / recent MI, hypotens., diab.  Plasma Li estim. to be done 12 hrs aft.last dos. on 5  or 7  day &
                                                                                           th
                                                                                         th
       mellit., psychos., bipol. disord.hist., discont.in case of jaund., discont.   insuffic., card.dis., conduct. disturbs., meds.that prolong QT interv.,   adjust.to keep Li lev.with.ther.range. Dos. accord.to pt.mass & age.
                                     ang.pect., recent MI, low bld.press., discont.if sympts.of infect.oc-
       if sympts.of infect.occur & do bld. counts, worsen. depress./emerg.  Plasma lev.to be determ. at wkly interv.dur.1  3 wks.
                                                                                     st
       suicid.ideat.& behav., monit.pts.caref.dur.early ther.& dos.chang.for   cur & do bld.counts, micturit.disturbs., ac. narr.angle glauc., incr.IOP,   Hypoman.& man: As per above & if pt.not too ill treatm.may be
                                     diab. mellit., wors.of psychot.sympts.e.g.when admin.to schizopren.,
       clinic. worsen./suicidality, co-morbid.betw.maj. depress.disord.&   init.as an out-pt.so long as facilit. avail.for plasma monit.avail.&
       other psych./non-psych.disords., consid.chang. therapeut.regim./  depress.phase of manic-depress.can transf.into manic phase, limit   init.within 1 wk.
                                     init.pt.supply, grad.withdr., discont. in case of jaund.
       discont.if psych. sympts.occur which are sev./abrupt in onset/not   Contraindications: Ren.& card.dis./fail., Addison’s dis., brain dam-
       part of pres.sympts., grad.withdr., concom. cimetidine/other CYP3A4   Drug interactions: Potent.CNS dampen.act.of alcoh., sedat.effs.  age evid., low sod. intake., pregn., breastfeed., congenit.long QT
                                     of benzodiazep.potent.
       induc./carbamazepine/ potent CYP3A4 inhibits., elderly, ren./hepat.   syndr., concom.meds.known to prolong QT interv.
       impairm., micturit.disturbs., clos.angle glauc., incr. IOP.  SANDOZ MIRTAZAPINE, Sandoz [P/S]  Side effects: Fatig., fine hand trem., slurr.speech, polyur., polydips.,
       Drug interactions: Ser.somet.fatal reacts.with MAOI, potent.sedat.  Mirtazapine  GI disturbs., thyrotoxicos., atax., dizzin., blurr.vis., tinnit., card.dys-
       effs.with alcoh./ benzodiazepin., bioavail.doubl.by cimetidine, sedat.  Indications: Maj.depress.  rhythm., ECG/EEG chang., oed., hypertens., periph.circulat.collapse,
       effs.of anxiolyt.& hypnot.potent., incr.clear. with carbamazepine/other   (S5) TABS. A40/1.2/0584, 0585.  leucocytos., antinucl. antibod.incr., allerg.vasculit., hypotens., syn-
       CYP3A4 induc., rais. plasma lev.with ketoconazole, hypotens.eff.of   707189-001: 15 mg, 30, R241,51  cope, stupor, confus., nystagm., epileptif.seiz., vertigo, musc.rigid.,
       clonidine poss.antagon.       708304-001: 30 mg, 30, R352,25  urine & faeces incont., somnol., psychomot.retardat., restlessn.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page51.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>&nbsp;&nbsp;&nbsp;<a href="page48.html">48</a>&nbsp;&nbsp;&nbsp;<a href="page49.html">49</a>&nbsp;&nbsp;&nbsp;<a href="page50.html">50</a>&nbsp;&nbsp;&nbsp;<a href="page51.html">51</a>&nbsp;&nbsp;&nbsp;<a href="page52.html">52</a>&nbsp;&nbsp;&nbsp;<a href="page53.html">53</a>&nbsp;&nbsp;&nbsp;<a href="page54.html">54</a>&nbsp;&nbsp;&nbsp;<a href="page55.html">55</a>&nbsp;&nbsp;&nbsp;<a href="page56.html">56</a>&nbsp;&nbsp;&nbsp;<a href="page57.html">57</a>
             </td>
             <td width="35%"><a href="page53.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page53.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
